Opioid awareness: Stigma, intervention and resources, with David A. Fiellin, MD, Part 1

Physicianary

In this episode, host Hansa Bhargava, MD, discusses opioid awareness, the stigma surrounding the opioid crisis and the resources for intervention with David A. Fiellin, MD.

• Intro 0:23
• David A. Fiellin 0:29
• Tell us about yourself and your work with opioid awareness. 0:50
• What are your insights on the deaths related to the opioid crisis? 2:07
• Tell us about the inequities of the opioid crisis. 4:07
• Do you feel educational campaigns have made an impact on opioid awareness? Where do we still have work left to do? 6:56
• Tell us about the stigma surrounding the opioid crisis. 9:02
• Tell us about how physician reluctance and hesitance to intervene can impact the opioid crisis. 11:45
• Visit pcssnow.org for more opioid use disorder support 13:46
• How can we make an impact on the opioid crisis, as well as other drug addiction crises? 14:57
• Are there inadequate resources for the opioid crisis or is there an inefficiency in using the resources? 19:06
• Thanks 22:40

David A. Fiellin, MD, is a professor of medicine, emergency medicine and public health at Yale. He directs the Yale program in addiction medicine and is vice chief for faculty affairs, general internal medicine. He is an internal medicine physician with board certified in addiction medicine. He conducts research focused on improving access to treatment for unhealthy substance use in general medical settings including office-based practice, primary care, emergency departments, hospitals and HIV specialty settings. He is editor-in-chief is of the Journal of Addiction Medicine and served as co-editor of the American Society of Addiction Medicine’s textbook, Principles of Addiction Medicine, fourth, fifth and sixth editions.

We’d love to hear from you! Send your comments/questions to Dr. Bhargava at [e-mail]. Follow Dr. Bhargava on X @hansabhargavaMD and on Instagram @doctorhansaMD. Follow Dr. Fiellin on X @YaleADM, on Instagram @yaleaddictionmed and on LinkedIn.

Disclosures: Bhargava and Fiellin report no relevant financial disclosures.